Sponsored by
Agentkit
MBZUAI / BiMediX2-8B
Model's Last Updated: December 16 2024
image-text-to-text
Introduction of BiMediX2-8B
Model Details of BiMediX2-8B
BiMediX2 : Bio-Medical EXpert LMM for Diverse Medical Modalities
BiMediX2-8B English Model
Mohamed Bin Zayed University of Artificial Intelligence (MBZUAI), UAE
License & Citation
BiMediX2 is released under the CC-BY-NC-SA 4.0 License. For more details, please refer to the LICENSE file included in our BiMediX repository.
⚠️ Warning! This release, intended for research, is not ready for clinical or commercial use.
Users are urged to employ BiMediX2 responsibly, especially when applying its outputs in real-world medical scenarios. It is imperative to verify the model's advice with qualified healthcare professionals and not rely on it for medical diagnoses or treatment decisions. Despite the overall advancements BiMediX2 shares common challenges with other language models, including hallucinations, toxicity, and stereotypes. BiMediX2's medical diagnoses and recommendations are not infallible.
If you use BiMediX2 in your research, please cite our work as follows:
@misc{mullappilly2024bimedix2biomedicalexpertlmm,
title={BiMediX2: Bio-Medical EXpert LMM for Diverse Medical Modalities},
author={Sahal Shaji Mullappilly and Mohammed Irfan Kurpath and Sara Pieri and Saeed Yahya Alseiari and Shanavas Cholakkal and Khaled Aldahmani and Fahad Khan and Rao Anwer and Salman Khan and Timothy Baldwin and Hisham Cholakkal},
year={2024},
eprint={2412.07769},
archivePrefix={arXiv},
primaryClass={cs.CV},
url={https://arxiv.org/abs/2412.07769},
}
Runs of MBZUAI BiMediX2-8B on huggingface.co
21
Total runs
-2
24-hour runs
0
3-day runs
3
7-day runs
2
30-day runs
More Information About BiMediX2-8B huggingface.co Model
Url of BiMediX2-8B
BiMediX2-8B huggingface.co Url
Provider of BiMediX2-8B huggingface.co
Other API from MBZUAI
Total runs:
2.6K
Run Growth:
-2.6K
Growth Rate:
-98.22%
Total runs:
1.7K
Run Growth:
-385
Growth Rate:
-23.05%
Total runs:
1.3K
Run Growth:
-7
Growth Rate:
-0.53%
Total runs:
1.1K
Run Growth:
-1.4K
Growth Rate:
-126.49%
Total runs:
1.1K
Run Growth:
-1.2K
Growth Rate:
-110.15%
Total runs:
916
Run Growth:
-1.2K
Growth Rate:
-133.30%
Total runs:
824
Run Growth:
329
Growth Rate:
39.93%
Total runs:
783
Run Growth:
783
Growth Rate:
100.00%
Total runs:
521
Run Growth:
-145
Growth Rate:
-26.46%
Total runs:
475
Run Growth:
-67
Growth Rate:
-14.11%
Total runs:
431
Run Growth:
83
Growth Rate:
19.26%
Total runs:
264
Run Growth:
-1.1K
Growth Rate:
-410.39%
Total runs:
210
Run Growth:
135
Growth Rate:
64.29%
Total runs:
192
Run Growth:
47
Growth Rate:
24.48%
Total runs:
156
Run Growth:
-1.6K
Growth Rate:
-1019.87%
Total runs:
142
Run Growth:
39
Growth Rate:
27.46%
Total runs:
107
Run Growth:
18
Growth Rate:
16.82%
Total runs:
56
Run Growth:
-53
Growth Rate:
-94.64%
Total runs:
35
Run Growth:
10
Growth Rate:
28.57%
Total runs:
34
Run Growth:
10
Growth Rate:
29.41%
Total runs:
26
Run Growth:
6
Growth Rate:
23.08%
Total runs:
25
Run Growth:
8
Growth Rate:
32.00%
Total runs:
22
Run Growth:
10
Growth Rate:
45.45%
Total runs:
21
Run Growth:
10
Growth Rate:
47.62%
Total runs:
21
Run Growth:
8
Growth Rate:
38.10%
Total runs:
16
Run Growth:
4
Growth Rate:
25.00%
Total runs:
16
Run Growth:
6
Growth Rate:
37.50%
Total runs:
12
Run Growth:
2
Growth Rate:
16.67%
Total runs:
12
Run Growth:
3
Growth Rate:
25.00%
Total runs:
10
Run Growth:
-18
Growth Rate:
-180.00%
Total runs:
8
Run Growth:
-2
Growth Rate:
-25.00%
Total runs:
8
Run Growth:
2
Growth Rate:
25.00%
Total runs:
8
Run Growth:
0
Growth Rate:
0.00%
Total runs:
7
Run Growth:
-2
Growth Rate:
-28.57%
Total runs:
7
Run Growth:
-4
Growth Rate:
-57.14%
Total runs:
4
Run Growth:
-3
Growth Rate:
-75.00%
Total runs:
0
Run Growth:
0
Growth Rate:
0.00%
Total runs:
0
Run Growth:
0
Growth Rate:
0.00%
Total runs:
0
Run Growth:
0
Growth Rate:
0.00%
Total runs:
0
Run Growth:
0
Growth Rate:
0.00%
Total runs:
0
Run Growth:
0
Growth Rate:
0.00%